article thumbnail

Right-Wing or Left-Wing: Who Really Owns the Critique of Over-Medicalisation?

Mad in America

His proposed solution was to make it harder to qualify for sick leave and health support, aiming to reduce government spending on disability and healthcare. Second, it provides an enormously lucrative market in which multinational pharmaceutical companies can peddle their pharmaceuticals (we can cure you with our SSRIs).

article thumbnail

“War Cry For Change”: Veterans Launch Campaign for Informed Consent and Safe Deprescribing at the VA

Mad in America

His independent research into psychiatric drug harm and pharmaceutical industry corruption would eventually lead him to Mad in America, where he launched the Veterans’ & Military Families Initiative in 2019. Pharmaceutical influence over government has allowed this to go on as long as it has.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Iatrogenic Gaze: How We Forgot That Psychiatry Could Be Harmful

Mad in America

Doctors became hypnotized by the appearance of “science”, even if the literature they consulted was essentially pharmaceutical advertising. Such optimism would be disappointed by dwindling pharmaceutical progress in the later half of the century. When medications did cause harm, the doctors were completely blind to it.

article thumbnail

Don’t Give Symptom-Free People Alzheimer’s Drugs

Mad in America

From The Hastings Center : “A large government-funded study of solanezumab , an experimental Alzheimer’s drug that targets amyloid in the brain, has found no benefit in people with normal cognitive function who have elevated amyloid levels.

article thumbnail

On Not Becoming David Foster Wallace

Mad in America

Jon Jureidini was doing research into patient experiences of antidepressant withdrawal with a view to making submissions to government. In the prevailing Australian Government view, withdrawal symptoms affect a small minority and probably represents relapse to the original condition. I contacted him, and he graciously took me on.

article thumbnail

Labor trends to watch in 2024: A U.S. economic outlook and sector play-by-play

Work Life

But despite government incentives for green energy initiatives, financing that growth may be challenging amid high interest rates and material costs, which could lead to project delays. Pharmaceutical Pharmaceutical companies have had a difficult year: the industry is grappling with softening demand for COVID-19-related products.

article thumbnail

Appetite for hybrid working shows no sign of letting up at large firms

Workplace Insight

The report, “ Global Hiring Activity Trends & Signals – Q3 2023 ,” claims that sectors such as construction, insurance, banking & payments, technology and communications, and pharmaceuticals posted significant hybrid job roles during the third quarter (Q3) of 2023.